Phospholipase D2 anticorps (N-Term)

N° du produit ABIN927701

Détail du produit anti-Phospholipase D2 anticorps

Antigène: Phospholipase D2 (PLD2)

Épitope: N-Term

Reactivité: Humain, Souris, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Phospholipase D2 est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Souris, Boeuf (Vache)

Purification: Purified

Immunogène: PLD2 antibody was raised in rabbit using the N terminal of PLD2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

PLD2 Blocking Peptide, catalog no. 33R-6532, is also available for use as a blocking control in assays to test for specificity of this PLD2 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur Phospholipase D2

Antigène: Phospholipase D2 (PLD2)

Autre désignation: PLD2 (PLD2 Produits)

Synonymes: anticorps Pldc, anticorps PLD2, anticorps phospholipase D2, anticorps PLD2, anticorps Pld2, anticorps pld2, anticorps CpipJ_CPIJ013122, anticorps VDBG_00892

Sujet: Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control. Synonyms: Polyclonal PLD2 antibody, Anti-PLD2 antibody, phospholipase D2 antibody.

Pathways: Signalisation RTK, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling